ABDSEROTEC search AbDSerotec PARP1 products
includes other brands or spellings
|
| ip | | Serotec polyclonal anti-PARP-1 antibody was used in human HeLa cells and in immunoprecipitation to study the interaction between DNA ligase IIIalpha and poly (ADP-ribose) polymerase 1 in DNA single-strand break repair. |
BIOMOL INTERNATIONAL search BIOMOL International PARP1 products
includes other brands or spellings
|
| wb | | BioMol anti-PARP antibody (C-2-10) was used in western blot to investigate the role of human BVR in sodium arsenite (As) -mediated induction of HO-1 and in cytoprotection against apoptosis by small interference RNA-mediated gene silencing. |
| wb | | Biomol Research Laboratories mouse anti-PARP antibody was used in western blot to study the requirement of galectin-3 phosphorylation for its anti-apoptotic function and cell cycle Aarrest. |
| wb | | BioMol anti-PARP antibody was used in western blot to detect PARP in U937 cells incubated for 24 h with 1-mM SB or 2-µM SAHA ± 100-ng/ml TRAIL to study TRAIL/HDAC inhibitor-mediated cell death. |
| wb | | Biomol mouse monoclonal anti-PARP antibody was used in western blot to detect PARP in K562-R, LAMA-R and their parent cells treated with 1 µM imatinib mesylate. |
| wb | | BIOMOL Research Laboratories anti-PARP antibody was used in western blot to detect PARP in T24 and Hela cells. |
| wb | | Biomol anti-PARP antibody was used in human HeLa and HEK Cells and in western blot to study the cellular localization and the biological function of LZTR-1. |
| wb | | BioMol anti-poly (ADP-ribose) antibody (SA-216) was used in western blot to the tankyrase-2 and tankyrase-1 interacting with the same set of proteins and probable mediating overlapping functions, both at telomeres and in vesicular compartments. |
| wb | | BioMol Research Laboratories mouse monoclonal PARP antibody (C-2–10) was used in western blot to study the interactions between pharmacological MEK1/2 inhibitors and STI571 in Bcr/Abl-positive human leukemia cells. |
| wb | | BIOMOL Research Laboratories anti-PARP antibody was used in western blot to study the expression levels of the proteins hFis1, Drp1, and Opa1 that are involved in mitochondrial fission and fusion in mammalian cells. |
CELL SIGNALING TECHNOLOGY search Cell Signaling Technology PARP1 products
includes other brands or spellings
|
| chip | | Cell Signaling Technology rabbit polyclonal PARP antibody was used in ChIP assay to study the mechanism of transcriptional repression by PARP. |
| ic | | Cell Signaling anti-PARP1 antibody was used in immunocytochemistry to identify two novel components of the human NDC80 kinetochore complex. |
| wb | | Cell Signaling Technology poly ADP-ribose polymerase antibody was used in western blot to study intestinal epithelial barrier dysfunction by interferon gamma and tumor necrosis factor alpha. |
| wb | | Cell Signaling Technology anti-total PARP and anti-cleaved PARP antibodies were used in western blot to study the function of RNase L and c-Jun NH2-terminal kinase in the interferon antiviral response. |
| wb | | Cell Signaling Technology mouse anti-PARP antibody was used in western blot to study the role of MMS21/NSE2 in DNA repair. |
| wb | | Cell Signaling Technologies rabbit anti-human PARP-1 antibody was used in western blot to study the effect of poly (ADP-ribose) polymerase-1 on DNA fragmentation factor 40 nuclease activity. |
| wb | | Cell Signaling Technology anti-PARP antibody was used in western blot to detect PARP in cortical neurons infected with LacZ or p75NTR recombinant adenovirus. |
| wb | | Cell Signaling Technology polyclonal anti-human PARP antibody (9542) was used in human heLa nuclei and in western blot to study the role of caspase-7 during the early stages of apoptosis. |
| wb | | New England Biolabs mouse anti-human PARP antibody was used in western blot to detect PARP in PAK4 knockdown (RNAi) cells untreated or treated with TNFalpha+CHX to induce apoptosis. |
| wb | | Cell Signaling Technology PARP antibody was used in western blot to study apoptotic induction by apicidin in human Bcr-Abl-positive leukemia cells. |
| wb | | Cell Signaling rabbit polyclonal anti-PARP antibody was used in human embryonic kidney (HEK293T) and human cervical carcinoma (HeLa) cells and in western blot to study the expression of HIAP2 during ER stress and the effect of it on stress-induced cell death. |
| wb | | Cell Signaling Technology polyclonal anti-PARP antibody was used in western blot to detect PARP in AZ-521 human gastric adenocarcinoma cells. |
| wb | | Cell Signaling Technology polyclonal anti-poly (ADP-ribose) polymerase (PARP) antibody was used in human HeLa cervical carcinoma cells and in western blot to study the roles of TIA-1 and HuR in the translation of cytochrome c. |
| wb | | Cell Signaling anti-PARP was used in western blot to detect PARP in ovarian cancer cell line A2780. |
| wb | | Cell Signaling Technology rabbit polyclonal anticleaved-poly (ADP-ribose) polymerase (PARP) antibody was used in western blot to study FHIT activity during bladder cancer development. |
| wb | | Cell Signaling Technology PARP (number 9542) was used in western blot to study the proapoptotic signaling pathways in interleukin-18-mediated human cardiac endothelial cell death. |
| wb | | Cell Signaling Technology antibody against cleaved PARP was used in western blot to study the critical role of the mTOR-dependent suppression of protein phosphatase 2A for phospholipase D survival signals in human breast cancer cells. |
| wb | | Cell Signaling Technology rabbit polyclonal anti-PARP antibody was used in western blot to study the selective induction of apoptosis by synthetic retinoid CD437 in human lung cancer cells. |
| wb | | Cell Signaling Technology poly (ADP-ribose) polymerase antibody was used in western blot to demonstrate multiple levels of molecular cross-talk between the TRAIL and interferon signaling pathways. |
| wb | | Cell Signaling Technology PARP antibody was used in western blot to study the mechanisms of hydrogen peroxide-induced apoptosis prevented by tBHQ in IMR-32 cells. |
| wb | | Cell Signaling Technology rabbit polyclonal anti-PARP antibody was used in western blot to study expression of secreted frizzled-related protein 4 in normal and malignant human prostate tissue.. |
| wb | | Cell Signaling anti-PARP polyclonal antibody was used in western blot to investigate the protective effects inositol hexakisphosphate (InsP6) has on HEK293 cells from induced apoptosis. |
| wb | | Cell Signaling anti-cleaved-PARP antibody was used in western blot to study the induction of neuroblastoma cell apoptosis by TrkA. |
| wb | | Cell Signaling poly (ADP-ribose) polymerase antibody was used in western blot to study apoptotic cell death in prostate cancer caused by androgen receptor silencing. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology PARP1 products
includes other brands or spellings
|
| wb | | Santa Cruz Biotechnology rabbit anti-PARP-1 antibody was used in western blot to study the organization of Immediate Early Gene X1 (IEX-1) in subnuclear structures and co-localization partially with promyelocytic leukemia protein in HeLa cells. |
| wb | | Santa Cruz Biotechnology goat anti-PARP1 was used in western blot to investigate PARP1 expression in HeLa S3 cells. |
| wb | | Santa Cruz Biotechnology polyclonal anti-poly (ADP-ribose) polymerase antibody H-250 was used in human T-cell lymphoblastic leukemia cell line CCRF-HSB-2 cells and in western blot to study the taxol-induced caspase-10-dependent apoptosis. |
| wb | | Santa Cruz Biotechnology rabbit polyclonal antibody against poly (ADP-ribose) polymerase (PARP, H-250) was used in western blot to detect the nuclear marker PARP in human HEK293-derived cell lines CATXalpha. |
| wb | | Santa Cruz monoclonal anti-poly (ADP-ribose) polymerase (PARP) antibody was used in human heLa cells and in western blot to study the role for heterogeneous nuclear ribonucleoprotein C in modulating translation of c-myc mRNA in a cell cycle phase-dependent manner. |
| wb | | Santa Cruz Biotechnology anti-PARP (sc-8007) antibody was used in Western blot to study the biological function of TRAIL induced apoptosis in human colon cells. |
| wb | | Santa Cruz Biotechnology PARP antibody was used in western blot to study the effect of 14-3-3 protein cleavage during apoptosis. |
| wb | | Santa Cruz PARP antibody was used in western blot to study the mechanism by which WISP-1 promotes tumorigenicity. |
R & D SYSTEMS search R & D Systems PARP1 products
includes other brands or spellings
|
| wb | | R&D Systems goat polyclonal PARP antibody was used in western blot to study the mechanism of transcriptional repression by PARP. |
BD BIOSCIENCES search BD Biosciences PARP1 products
includes other brands or spellings
|
| ic | | BD Transduction Laboratories mouse monoclonal PARP antibody was used in immunocytochemistry to characterize the interaction between RanBP2 and Ubc9. |
| wb | | BD Biosciences PharMingen mouse anti-human poly (ADP-ribose) polymerase (PARP) was used in western blot to study the role of caspase-resistant golgin-160 to disrupt apoptosis induced by secretory pathway stress and ligation of death receptors. |
| wb | | Transduction Lab antibody against PARP was used in western blot to investigate the cellular effects of herba houttuyniae extract (HHE) and the signal pathways of HHE-induced apoptosis in HL-60 human promyelocytic leukemia cell line. |
| wb | | Pharmingen anti-poly- (D-ribose) polymerase antibody was used in western blot to study the regulation of cell adhesion and migration by presenilin/gamma-secretase-mediated cleavage of the voltage-gated sodium channel beta2-Subunit. |
| wb | | BD PharMingen mouse monoclonal poly (ADP-ribose) polymerase (PARP) antibody was used in western blot to study asthmatic airway remodeling and reactivity. |
| wb | | BD Pharmingen mouse anti-PARP antibody was used in western blot to study the effect of ERK kinase inhibition on the Aryl hydrocarbon receptor. |
| wb | | PharMingen mouse anti-human poly (ADP-ribose) polymerase (PARP) antibody was used in western blot to detect the PARP in the T84 human colon epithelial cells, HCA-7 human colon epithelial cells and RIE-1 normal rat intestinal epithelial cells to study the apoptosis of normal and transformed intestinal epithelial cells. |
| wb | | BD Pharmingen anti-PARP antibody was used in western blot to detect PARP in U373 cells with human MEKK3 stable transfection. |
| wb | | Transduction Laboratories anti-PARP was used in western blot to detect the presence of PARP in Jurkat cells. |
| wb | | PharMingen mouse monoclonal anti-PARP antibody was used in western blot to detect PARP in HCT116 p53+/+ cells treated with no drug, 5-FU, or RTX, alone or in combination with CH-11. |
| wb | | Pharmingen monoclonal anti-PARP antibody was used in western blot to detect PARP in Jurkat cells treated with phytosphingosine. |
| wb | | Pharmingen monoclonal anti-human poly (ADP-ribose) polymerase (PARP) antibody was used in primary human keratinocytes and in western blot to study the role for IGF-1 in this delay of the onset of apoptosis through activation of the AKT signaling pathway. |
| wb | | BD Pharmingen anti-PARP monoclonal antibody was used in western blot to detect PARP in cytosolic fraction or total cell lysates of NCI-H1299 cells. |
| wb | | BD Pharmingen mouse monoclonal anti-PARP antibody was used in parental A431 human vulvar epidermoid carcinoma cells and in western blot to study the function for Dsg1 in facilitating apoptotic elimination of damaged cells. |
| wb | | BD Biosciences mouse monoclonal anti-PARP antibody was used in human carcinoma cells and in western blot to study the effect of DNA damage-induced expression of p53 on mitotic checkpoint kinase hMps1. |
| wb | | BD Biosciences monoclonal antibody to Poly (ADP-ribose) polymerase (PARP) was used in western blot in the study of fibronectin protecting prostate cancer cells from tumor necrosis factor-alpha-induced aoptosis via the AKT/Survivin pathway. |
| wb | | BD Biosciences PARP antibody was used in western blot to study RhoB protective effect from UVB-induced apoptosis in human keratinocytes. |
| wb | | BD Biosciences mouse monoclonal poly (ADP-ribose) polymerase (PARP) antibody was used in western blot to study tumor necrosis factor-alpha signaling pathways. |
| wb | | PharMingen poly (ADP-ribose) polymerase (7D3-6) antibody was used in western blot to study the induction of the BCL-6 transcriptional repressor by forkhead transcription factor AFX. |
EMD BIOSCIENCES search EMD Biosciences PARP1 products
includes other brands or spellings
|
| wb | | Oncogene anti-PARP antibody was used in western blot to detect PARP in cytosolic extracts from HeLa cells untreated or incubated with cytochrome c and dATP in the presence or absence of NS3694, DEVD-CHO and zVAD-fmk to study cell apoptosis. |
ABCAM search Abcam PARP1 products
includes other brands or spellings
|
| wb | | abcam antibody against poly (ADP-ribose) polymerase was used in western blot to gain further understanding of the mechanisms underlying 5-FU resistance in colorectal cancer cells by investigating mGluR4 expression. |
MILLIPORE search Millipore PARP1 products
includes other brands or spellings
|
| wb | | Upstate Biotechnology anti-poly- (ADP-ribose) polymerase (PARP) antibody was used in western blot to study the requirement for the translocation of the 91-kDa caspase cleavage MEKK1 fragment to a soluble cytoplasmic fraction during the induction of apoptosis. |
INVITROGEN search Invitrogen PARP1 products
includes other brands or spellings
|
| wb | | Zymed Laboratories monoclonal anti-PARP-1 antibody was used in western blot to detect PARP-1 in the nuclear extracts of human HeLa cells, mouse EM9 cells (XRCC1 mutant), AA8 (parental Chinese hamster) cells, and PARP-1–/–mouse embryonic fibroblasts. |
TREVIGEN search Trevigen PARP1 products
|
| ip, wb | | Trevigen anti-PARP-1 antibody was used in human HeLa cells and in western blot, immunoprecipitation to study the interaction between DNA ligase IIIalpha and poly (ADP-ribose) polymerase 1 in DNA single-strand break repair. |
EBIOSCIENCE search eBioscience PARP1 products
includes other brands or spellings
|
| ic, wb | | eBioscience PARP antibody was used in western blot to investigate the effect of mitochondrial stress on p21 expression and cell apoptosis. |
PROMEGA search Promega PARP1 products
|
| ic | | Promega rabbit anti-PARP-p89 fragment antibody was used in human carcinoma cells and in immunocytochemistry to study the effect of DNA damage-induced expression of p53 on mitotic checkpoint kinase hMps1. |
| wb | | Promega polyclonal anti-poly (ADP-ribose) polymerase p85 fragment antibody was used in western blot to detect poly (ADP-ribose) polymerase p85 fragment in MiaPaca-2 or Panc-1 cells. |
ALEXIS search Alexis PARP1 products
includes other brands or spellings
|
| wb | | Alexis anti-PARP antibody was used in western blot to detect PARP in parental, FADD-deficient, and caspase-8-deficient Jurkat cells treated with TNF in the presence of cycloheximide for the indicated times. |
ROCHE APPLIED SCIENCE search Roche Applied Science PARP1 products
includes other brands or spellings
|
| wb | | Roche rabbit polyclonal anti-poly (ADP-ribose) polymerase antibody was used in western blot to study apoptotic association of active caspase 8 with the mitochondrial membrane. |
| wb | | Roche Molecular Biochemicals rabbit anti-cleaved poly (ADP-ribose) polymerase (PARP) (p85) antibody was used in western blot to study the induction a Fas-associated death domain-dependent type II apoptotic pathway by tissue inhibitor of metalloproteinase-3. |
| wb | | Roche antibody against PARP was used in western blot to investigate the oxidant-induced cell death in retinal pigment epithelium cells mediated through the release of apoptosis-inducing factor. |
| wb | | Roche anti-poly (ADP-ribose) polymerase (PARP) antibody was used in western blot to study the effect of protein kinase CK2 inhibitor 4, 5, 6, 7-tetrabromobenzotriazole (TBB) on apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells. |
BIOMOL
|
| wb | | BioMol anti-PARP antibody (C-2-10) was used in western blot to investigate the role of human BVR in sodium arsenite (As) -mediated induction of HO-1 and in cytoprotection against apoptosis by small interference RNA-mediated gene silencing. |
| wb | | BioMol anti-PARP antibody was used in western blot to detect PARP in U937 cells incubated for 24 h with 1-mM SB or 2-µM SAHA ± 100-ng/ml TRAIL to study TRAIL/HDAC inhibitor-mediated cell death. |
| wb | | Biomol mouse monoclonal anti-PARP antibody was used in western blot to detect PARP in K562-R, LAMA-R and their parent cells treated with 1 µM imatinib mesylate. |
| wb | | Biomol anti-PARP antibody was used in human HeLa and HEK Cells and in western blot to study the cellular localization and the biological function of LZTR-1. |
| wb | | BioMol anti-poly (ADP-ribose) antibody (SA-216) was used in western blot to the tankyrase-2 and tankyrase-1 interacting with the same set of proteins and probable mediating overlapping functions, both at telomeres and in vesicular compartments. |
CLONTECH LABORATORIES
|
| wb | | CLONTECH laboratories mouse monoclonal anti-PARP antibody was used in U373MG, IMR-32, or SK-N-AS cells and in western blot to study the role for p73 in HCMV-mediated inhibition of apoptosis. |
ENZYME SYSTEM PRODUCTS
|
| wb | | Enzyme System Products anti-poly (ADP-ribose) polymerase C2.10 antibody was used in western blot to study the role of AIF in nuclear phenotype and DNA degradation during apoptosis. |
Articles Reviewed |
| 1. Chandan Kumar-Sinha et al. Molecular cross-talk between the TRAIL and interferon signaling pathways. 2002 |
| 2. Viatcheslav A Soldatenkov et al. Transcriptional repression by binding of poly(ADP-ribose) polymerase to promoter sequences. 2002 |
| 3. Jiang Li et al. Microarray analysis reveals an antioxidant responsive element-driven gene set involved in conferring protection from an oxidative stress-induced apoptosis in IMR-32 cells. 2002 |
| 4. Hisato Saitoh et al. Perturbation of SUMOlation enzyme Ubc9 by distinct domain within nucleoporin RanBP2/Nup358. 2002 |
| 5. Tadashi Yoshii et al. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. 2002 |
| 6. Tracy Tzu-Ling Tang et al. The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor. 2002 |
| 7. Chunrong Yu et al. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells. 2002 |
| 8. Fei Su et al. WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. 2002 |
| 9. Thomas K Schlesinger et al. Apoptosis stimulated by the 91-kDa caspase cleavage MEKK1 fragment requires translocation to soluble cellular compartments. 2002 |
| 10. Juan I Sbodio et al. Tankyrase-2 oligomerizes with tankyrase-1 and binds to both TRF1 (telomere-repeat-binding factor 1) and IRAP (insulin-responsive aminopeptidase). 2002 |
| 11. Mark Bond et al. Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway. 2002 |
| 12. Shi-Yong Sun et al. The synthetic retinoid CD437 selectively induces apoptosis in human lung cancer cells while sparing normal human lung epithelial cells. 2002 |
| 13. Maria Ruzzene et al. Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells. 2002 |
| 14. Sophie Allart et al. Human cytomegalovirus induces drug resistance and alteration of programmed cell death by accumulation of deltaN-p73alpha. 2002 |
| 15. David Decraene et al. Insulin-like growth factor-1-mediated AKT activation postpones the onset of ultraviolet B-induced apoptosis, providing more time for cyclobutane thymine dimer removal in primary human keratinocytes. 2002 |
| 16. Zhong-Zong Pan et al. Gamma-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways. 2002 |
| 17. Makoto Kamachi et al. Human autoimmune sera as molecular probes for the identification of an autoantigen kinase signaling pathway. 2002 |
| 18. Jong Heon Kim et al. Heterogeneous nuclear ribonucleoprotein C modulates translation of c-myc mRNA in a cell cycle phase-dependent manner. 2003 |
| 19. Congxiao Zhang et al. Oxidant-induced cell death in retinal pigment epithelium cells mediated through the release of apoptosis-inducing factor. 2003 |
| 20. Nicholas Harper et al. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis. 2003 |
| 21. Yun-Song Lee et al. Expression of hOGG1 protein during differentiation of HL-60 cells. 2003 |
| 22. Jia-Hao Xiao et al. Adenomatous polyposis coli (APC)-independent regulation of beta-catenin degradation via a retinoid X receptor-mediated pathway. 2003 |
| 23. Hiroshi Nishihara et al. Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2. 2003 |
| 24. John B Leppard et al. Physical and functional interaction between DNA ligase IIIalpha and poly(ADP-Ribose) polymerase 1 in DNA single-strand break repair. 2003 |
| 25. Moon-Taek Park et al. Suppression of extracellular signal-related kinase and activation of p38 MAPK are two critical events leading to caspase-8- and mitochondria-mediated cell death in phytosphingosine-treated human cancer cells. 2003 |
| 26. Mara Fornaro et al. Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway. 2003 |
| 27. Nico Hendrickx et al. Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells. 2003 |
| 28. Ulrik Lademann et al. Diarylurea compounds inhibit caspase activation by preventing the formation of the active 700-kilodalton apoptosome complex. 2003 |
| 29. Geqiang Li et al. An apoptotic signaling pathway in the interferon antiviral response mediated by RNase L and c-Jun NH2-terminal kinase. 2004 |
| 30. June-Won Cheong et al. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells. 2003 |
| 31. Nadia Korfali et al. Caspase-7 gene disruption reveals an involvement of the enzyme during the early stages of apoptosis. 2004 |
| 32. Woojin Jeong et al. Roles of TRP14, a thioredoxin-related protein in tumor necrosis factor-alpha signaling pathways. 2004 |
| 33. Ajoy K Samanta et al. Overexpression of MEKK3 confers resistance to apoptosis through activation of NFkappaB. 2004 |
| 34. Asha L Bhakar et al. Apoptosis induced by p75NTR overexpression requires Jun kinase-dependent phosphorylation of Bad. 2003 |
| 35. Rajnish Bharadwaj et al. Identification of two novel components of the human NDC80 kinetochore complex. 2004 |
| 36. Jyothisri Kondapalli et al. Laminar shear stress differentially modulates gene expression of p120 catenin, Kaiso transcription factor, and vascular endothelial cadherin in human coronary artery endothelial cells. 2004 |
| 37. Roberto R Rosato et al. Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells. 2003 |
| 38. Lisa G Horvath et al. Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro. 2004 |
| 39. Bysani Chandrasekar et al. Activation of intrinsic and extrinsic proapoptotic signaling pathways in interleukin-18-mediated human cardiac endothelial cell death. 2004 |
| 40. Dinesh Warnakulasuriyarachchi et al. Translational induction of the inhibitor of apoptosis protein HIAP2 during endoplasmic reticulum stress attenuates cell death and is mediated via an inducible internal ribosome entry site element. 2004 |
| 41. Amin Safari et al. The human Rap1 protein complex and modulation of telomere length. 2004 |
| 42. Daniel Broderick Longley et al. The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites. 2004 |
| 43. Yun Dai et al. A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2. 2004 |
| 44. Byong Chul Yoo et al. Metabotropic glutamate receptor 4-mediated 5-Fluorouracil resistance in a human colon cancer cell line. 2004 |
| 45. Dhyan Chandra et al. Association of active caspase 8 with the mitochondrial membrane during apoptosis: potential roles in cleaving BAP31 and caspase 3 and mediating mitochondrion-endoplasmic reticulum cross talk in etoposide-induced cell death. 2004 |
| 46. Yang-Ja Lee et al. Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. 2004 |
| 47. Soo-Jung Park et al. Taxol induces caspase-10-dependent apoptosis. 2004 |
| 48. Marc Audebert et al. Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. 2004 |
| 49. Ahmad L Subhi et al. Loss of methylthioadenosine phosphorylase and elevated ornithine decarboxylase is common in pancreatic cancer. 2004 |
| 50. Andrea Vecchione et al. Inactivation of the FHIT gene favors bladder cancer development. 2004 |
| 51. Shujuan Chen et al. ERK kinase inhibition stabilizes the aryl hydrocarbon receptor: implications for transcriptional activation and protein degradation. 2005 |
| 52. Fengjun Wang et al. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. 2005 |
| 53. James D West et al. Modulation of DNA fragmentation factor 40 nuclease activity by poly(ADP-ribose) polymerase-1. 2005 |
| 54. Tihomir Miralem et al. Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells. 2005 |
| 55. Suzy A A Comhair et al. Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity. 2005 |
| 56. Konstantinos G Drosopoulos et al. Transformation by oncogenic RAS sensitizes human colon cells to TRAIL-induced apoptosis by up-regulating death receptor 4 and death receptor 5 through a MEK-dependent pathway. 2005 |
| 57. Xinbo Liao et al. Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer. 2005 |
| 58. Rebecca S Maag et al. Caspase-resistant Golgin-160 disrupts apoptosis induced by secretory pathway stress and ligation of death receptors. 2005 |
| 59. Doo Yeon Kim et al. Presenilin/gamma-secretase-mediated cleavage of the voltage-gated sodium channel beta2-subunit regulates cell adhesion and migration. 2005 |
| 60. Marie-Luise Kruse et al. Immediate early gene X1 (IEX-1) is organized in subnuclear structures and partially co-localizes with promyelocytic leukemia protein in HeLa cells. 2005 |
| 61. Ching-Hao Li et al. Chloramphenicol-induced mitochondrial stress increases p21 expression and prevents cell apoptosis through a p21-dependent pathway. 2005 |
| 62. Jean-François Lavoie et al. TrkA induces apoptosis of neuroblastoma cells and does so via a p53-dependent mechanism. 2005 |
| 63. John Verbsky et al. Increased levels of inositol hexakisphosphate (InsP6) protect HEK293 cells from tumor necrosis factor (alpha)- and Fas-induced apoptosis. 2005 |
| 64. Victor J Yuste et al. The contribution of apoptosis-inducing factor, caspase-activated DNase, and inhibitor of caspase-activated DNase to the nuclear phenotype and DNA degradation during apoptosis. 2005 |
| 65. Patrick Ryan Potts et al. Human MMS21/NSE2 is a SUMO ligase required for DNA repair. 2005 |
| 66. Li Hui et al. mTOR-dependent suppression of protein phosphatase 2A is critical for phospholipase D survival signals in human breast cancer cells. 2005 |
| 67. Xiaofan Li et al. PAK4 functions in tumor necrosis factor (TNF) alpha-induced survival pathways by facilitating TRADD binding to the TNF receptor. 2005 |
| 68. Bruno Canguilhem et al. RhoB protects human keratinocytes from UVB-induced apoptosis through epidermal growth factor receptor signaling. 2005 |
| 69. Rachel L Dusek et al. The differentiation-dependent desmosomal cadherin desmoglein 1 is a novel caspase-3 target that regulates apoptosis in keratinocytes. 2006 |
| 70. Tanju G Nacak et al. The BTB-kelch protein LZTR-1 is a novel Golgi protein that is degraded upon induction of apoptosis. 2006 |
| 71. Soon-Young Choi et al. Activation of Bak and Bax through c-abl-protein kinase Cdelta-p38 MAPK signaling in response to ionizing radiation in human non-small cell lung cancer cells. 2006 |
| 72. Eiki Yamasaki et al. Helicobacter pylori vacuolating cytotoxin induces activation of the proapoptotic proteins Bax and Bak, leading to cytochrome c release and cell death, independent of vacuolation. 2006 |
| 73. Mandar R Bhonde et al. DNA damage-induced expression of p53 suppresses mitotic checkpoint kinase hMps1: the lack of this suppression in p53MUT cells contributes to apoptosis. 2006 |
| 74. Tomoko Kawai et al. Translational control of cytochrome c by RNA-binding proteins TIA-1 and HuR. 2006 |